Intensity Therapeutics, Inc.:Benchmark将目标价调整至12美元,此前为1.50美元,以反映并股影响

美股速递
Mar 31

投资机构Benchmark近日宣布,对Intensity Therapeutics, Inc.的目标股价作出调整,从原先的1.50美元上调至12美元。此次调整主要基于该公司近期实施的并股操作,旨在更准确地反映其股票实际价值。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10